Por si es de vuestro interés, os informamos de la siguiente oferta de trabajo:
The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between academic, government, and philanthropic institutions to contribute to the efforts undertaken by the international community to address the challenges in global health. ISGlobal provides a hub of excellence dedicated to scientific research and the provision of health care. The institute, which originated in a joint initiative of the Hospital Clínic de Barcelona and the University of Barcelona, has amassed over 30 years of experience in the field of global health. The pivotal mechanism of its work model is the transfer of knowledge generated by scientific research to practice, a task undertaken by the Research, Training and Policy and Global Development departments. Its ultimate goal is to help close the gaps in health disparities between and within different regions of the world.
ISGlobal is seeking a junior Social Anthropologist to work under the supervision of the senior Social Anthropologist for the project “Transforming Intermittent Preventive Treatment for Optimal Pregnancy” (TIPTOP). The project goal of this project is to contribute at reducing maternal and neonatal mortality by expanding access to intermittent preventive treatment in pregnancy (IPTp) with quality-assured (QA) sulfadoxine-pyrimethamine (SP).
The five-year project, funded by UNITAID and coordinated by Jhpiego, an affiliate of Johns Hopkins University, will increase malaria in pregnancy IPTp-SP coverage and expand antenatal care attendance primarily through Community Health Workers (CHW) in four African countries – Democratic Republic of Congo, Madagascar, Mozambique and Nigeria. The Jhpiego-led consortium includes Jhpiego as principal recipient and implementing partner responsible to Unitaid for the implementation of the Project and ISGlobal, the Barcelona Institute for Global Health, as lead research and evaluation partner. The consortium will work closely with the World Health Organization (WHO) and Malaria Medicines Venture (MMV) as well as other stakeholders, to ensure that all project outputs are met.
The Project will establish a scalable model across four countries to generate evidence for change and expand access to preventive chemotherapy for pregnant women. TIPTOP will apply a community-based approach that fosters partnership and strengthens the dynamic link between communities and health facilities, especially for the most vulnerable people. A learning-driven approach will be employed throughout the project to guide expansion in a two-phase process and generate sufficient evidence to inform WHO policy recommendations and future actions in each country, in an effort to expand the intervention over the long-term.
ISGlobal is the lead evaluation and research organization and is responsible for implementing a set of studies to generate evidence for global guidance on community IPTp-SP. Specifically, ISGlobal will be responsible for designing and implementing the project’s evaluation plan, as well as designing, analyzing and reporting the operational research studies to assess the cost and acceptability and feasibility of the intervention and its impact. These will be done through household surveys, feasibility and acceptability studies, costing studies —and also assistance to ensure the quality of routine monitoring data.
Lugar:Barcelona – Campus Clínic